Propanc Biopharma Advances Bioanalytical and Immunogenicity Assay Development for Phase 1b Study

Article summary

Propanc Biopharma, Inc. announced the progression of key analytical development activities, including immunogenicity assay feasibility and pharmacokinetic method optimization, to support its upcoming Phase 1b clinical trial.